Galderma announces positive Phase 3 trial results of investigational adapalene 0.3%/benzoyl peroxide 2.5% (0.3% A/BPO) for the treatment of acne

Galderma Laboratories, L.P. has announced positive phase 3 trial results of adapalene 0.3%/benzoyl peroxide 2.5% (0.